Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Expansion of Peripheral Extra-Follicular Helper T Cells in Patients with Chronic Graft-Versus-Host Disease

Hua Jin, Kaibo Yang, Haiyan Zhang, Zhiping Fan, Fen Huang, Yanyan Chai, Li Xuan, Yanqiu Chen, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 4583.

https://doi.org/10.1182/blood-2018-99-113211

Published: 2018

Journal Articles

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

Juergen Foell, MD, Johannes Schulte, Anja Troeger, MD, Beatrix Pfirstinger, MD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Petra Hoffmann, PhD, Charalampos Aslanidis, PhD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD

Blood (2018) 132 (Supplement 1): 3455.

https://doi.org/10.1182/blood-2018-99-114695

Published: 2018

Journal Articles

High VEGF Serum Levels on Days +50 and +100 after Allogeneic Stem Cell Transplantation Predict Severe Chronic GvHD

Mark-Alexander Schwarzbich, MD, Lehners Nicola, MD, Katharina Schmidt, MD, Christine Falk, Anthony D. Ho, MD FRCPC, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2014) 124 (21): 1163.

https://doi.org/10.1182/blood.V124.21.1163.1163

Published: 2014

Journal Articles

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Marie Y. Detrait, MD, Roberto Crocchiolo, MD PhD, Stephane Vigouroux, MD, Jacques-Olivier Bay, MD, PhD, Mohamad Sobh, Pharm.M., Fiorenza Barraco, MD, Stéphane Morisset, Stat., Reza Tabrizi, MD, Nicole Raus, Regis Peffault de la Tour, Gérard Socié, MD PhD, Ibrahim Yakoub-Agha, MD, PhD, Mohamad Mohty, MD PhD, Noel Milpied, MD, Didier Blaise, MD, Mauricette Michallet, MD, PhD

Blood (2012) 120 (21): 1947.

https://doi.org/10.1182/blood.V120.21.1947.1947

Published: 2012

Journal Articles

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Yoshihiro Inamoto, MD, Barry Storer, PhD, Effie W. Petersdorf, MD, Paul A. Carpenter, MD, Stephanie J. Lee, MD, MPH, Lee Nelson, MD, Brenda M. Sandmaier, MD, Paul J. Martin, MD, Mary E.D. Flowers, MD

Blood (2011) 118 (21): 322.

https://doi.org/10.1182/blood.V118.21.322.322

Published: 2011

Journal Articles

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Finella Brito-Babapulle, Nicholas C.P. Cross

Blood (2007) 110 (11): 3310.

https://doi.org/10.1182/blood.V110.11.3310.3310

Published: 2007

Journal Articles

Multicenter Experience with Imatinib Mesylate in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients.

A.M. Carella, MD, E. Lerma, MD, E. Orlandi, MD, M. Lazzarino, MD, M. Annunziata, MD, F. Ferrara, MD, E. Pungolino, MD, E. Morra, MD, M. Miglino, MD, M. Gobbi, MD

Blood (2007) 110 (11): 4554.

https://doi.org/10.1182/blood.V110.11.4554.4554

Published: 2007

Journal Articles

Pentostatin: Efficacy in Refractory Chronic GVHD in Children.

David A. Jacobsohn, MD, ScM, Brittan Browning, MS, RD, Kimberly Thormann, RN, CRNP, Meghan Higman, MD, PhD, Michele L. Phelps, RN, Allen R. Chen, MD, PhD, Georgia B. Vogelsang, MD

Blood (2004) 104 (11): 2249.

https://doi.org/10.1182/blood.V104.11.2249.2249

Published: 2004

Journal Articles

Safety and Potential Efficacy of Low Dose Methotrexate for Treatment of Chronic Graft-Versus-Host Disease.

Mary E.D. Flowers, Luisa Giaccone, Vaneuza Funke, Paul A. Carpenter, Carina Moravec, Heather Hooper, Rainer F. Storb, Paul J. Martin

Blood (2004) 104 (11): 5112.

https://doi.org/10.1182/blood.V104.11.5112.5112

Published: 2004

NARROW

Expansion of Peripheral Extra-Follicular Helper T Cells in Patients with Chronic Graft-Versus-Host Disease

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

High VEGF Serum Levels on Days +50 and +100 after Allogeneic Stem Cell Transplantation Predict Severe Chronic GvHD

Risk Factors to Develop Sclerotic Chronic GvHD After Allogeneic HSCT: Preliminary Results of a Multicentre Retrospective study From the Société Française De Greffe De Moelle Et De Thérapie Cellulaire (SFGM-TC)

Incidence, Risk Factors and Outcomes of Sclerotic Chronic Graft-Versus-Host Disease (GVHD) Phenotype After Allogeneic Hematopoietic Cell Transplantation

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Multicenter Experience with Imatinib Mesylate in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients.

Pentostatin: Efficacy in Refractory Chronic GVHD in Children.

Safety and Potential Efficacy of Low Dose Methotrexate for Treatment of Chronic Graft-Versus-Host Disease.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only